We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+19.65%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$236M
AUM Growth
-$28.4M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
39.99%
Holding
134
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 29.03%
2 Financials 13.46%
3 Real Estate 13.05%
4 Technology 9.18%
5 Industrials 7.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PANL icon
101
Pangaea Logistics
PANL
$485M
– –
0
– –
ENPH icon
102
Enphase Energy
ENPH
$5.19B
– –
0
– –
TYME
103
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
– –
0
– –
CIC.WS
104
DELISTED
Capitol Investment Corp. IV
CIC.WS
– –
0
– –
SITO
105
DELISTED
SITO MOBILE, LTD
SITO
– –
0
– –
IOTS
106
DELISTED
Adesto Technologies Corp
IOTS
– –
0
– –
SRNE
107
DELISTED
Sorrento Therapeutics, Inc.
SRNE
– –
0
– –
ASYS icon
108
Amtech Systems
ASYS
$270M
– –
0
– –
HOS
109
DELISTED
Hornbeck Offshore Services, Inc.
HOS
– –
0
– –
SRUNW
110
DELISTED
Silver Run Acquisition Corporation II
SRUNW
– –
0
– –
CASI
111
DELISTED
CASI Pharmaceuticals
CASI
– –
0
– –
MRNS
112
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
– –
0
– –
CDNA icon
113
CareDx
CDNA
$2.35B
– –
0
– –
CGNT
114
DELISTED
Cogentix Medical, Inc.
CGNT
– –
0
– –
IMUX icon
115
Immunic
IMUX
$194M
– –
0
– –
CTSO icon
116
Cytosorbents Corp
CTSO
$25M
– –
0
– –
DMK
117
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
– –
0
– –
ARWR icon
118
Arrowhead Research
ARWR
$12.1B
– –
0
– –
SENS icon
119
Senseonics Holdings Inc
SENS
$270M
– –
0
– –
TTOO
120
DELISTED
T2 Biosystems, Inc
TTOO
– –
0
– –
KDMN
121
DELISTED
Kadmon Holdings, Inc.
KDMN
– –
0
– –
AVEO
122
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
– –
0
– –
OSPRW
123
DELISTED
Osprey Energy Acquisition Corp. Warrant
OSPRW
– –
0
– –
ECYT
124
DELISTED
Endocyte, Inc. Common Stock
ECYT
– –
0
– –
CDMO
125
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
– –
0
– –
2 3 4
5
6

Similar funds

SWMG
Sard Wealth Management Group Atlanta, Georgia $184M AUM 11.26% 1-Year Est. Return
IFPL
Investments & Financial Planning LLC Lexington, Kentucky $184M AUM 17.7% 1-Year Est. Return
RFG
RFP Financial Group Atlanta, Georgia $184M AUM 16.06% 1-Year Est. Return
NAM
Nutshell Asset Management Sevenoaks, United Kingdom $184M AUM 2.02% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
TCM
Tassel Capital Management Matthews, North Carolina $184M AUM 17.12% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
GCA
GSI Capital Advisors Newport Beach, California $184M AUM 5.17% 1-Year Est. Return

Monashee Investment Management's Q4 2017 Portfolio in Review

As of Q4 2017, Monashee Investment Management held 134 positions worth $236M, down 11% from $264M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Trading was light in Q4 2017: portfolio turnover was 0%. Monashee Investment Management opened no new positions and made no exits, leaving the 134-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 28% a quarter earlier, followed by Financials and Real Estate.

  • Monashee Investment Management's ten largest holdings make up 40% of its $236M portfolio in Q4 2017.
  • Monashee Investment Management opened 0 new positions and closed 0 in Q4 2017.
  • Monashee Investment Management's portfolio value fell 11% quarter-over-quarter to $236M.

Based on Monashee Investment Management's 13F filing for Q4 2017, filed 9 Feb 2018.